Stay updated with breaking news from 69404d10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) dropped 9.4% during mid-day trading on Tuesday . The company traded as low as $6.07 and last traded at $6.08. Approximately 1,930,162 shares changed hands during mid-day trading, a decline of 78% from the average daily volume of 8,629,338 shares. The stock had previously closed […]
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) is set to announce its 12/31/2023 earnings results after the market closes on Wednesday, February 14th. Analysts expect the company to announce earnings of ($0.31) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are presently covering the stock, Marketbeat reports. Five equities research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has earned a consensus rating of “Moderate Buy” from the thirteen research firms that are covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12-month […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has been given a consensus rating of “Moderate Buy” by the thirteen analysts that are presently covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average […]